Researchers find intensive blood pressure targets are cost-effective
Research led by investigators at Mass General Brigham suggests that the health benefits of more aggressive blood pressure control outweigh concerns about overtreating people with high blood pressure readings. Results of the simulation study are published in Annals of Internal Medicine.
The study used data from the Systolic Blood Pressure Intervention Trial (SPRINT) trial, the National Health and Nutrition Examination Survey (NHANES), and other published literature to simulate lifetime health outcomes—including heart attack, stroke, and heart failure—for patients whose systolic blood pressure targets were set at <120 mm Hg, <130 mm Hg, and <140 mm Hg. Recognizing ...